CELL INTELLIGENCE · 肿瘤细胞治疗研究

超越免疫检查点阻断：T 细胞衔接器与抗体药物偶联物在癌症与自身免疫性疾病中的应用

Beyond immune checkpoint blockade: T cell engagers and antibody-drug conjugates in cancer and autoimmune disease.

智胜抗原逃逸：用于血液系统恶性肿瘤持久缓解的下一代 CAR-T 细胞工程策略

Outsmarting Antigen Escape: Next-Generation CAR T Cell Engineering Strategies for Durable Remissions in Hematologic Malignancies.

CAR-T 细胞治疗前基于苯达莫司汀的淋巴细胞清除：一项系统综述

Bendamustine-based lymphodepletion prior to CAR T-cell therapy: a systematic review.

接受抗 BCMA CAR-T 细胞治疗的多发性骨髓瘤患者的病毒再激活

Viral Reactivation in Multiple Myeloma Patients Receiving Anti-BCMA Chimeric Antigen Receptor T-Cell Therapy.

超越 CAR-T：CAR-NK/T 细胞在血液肿瘤中的兴起

Beyond CAR-T: The Rise of CAR-NK/T Cells for Haematological Cancer.

CAR-NK/T 细胞可能被证明是治疗血液系统恶性肿瘤的一种更安全、更灵活的细胞疗法。

释放 CAR-T 细胞治疗的潜力：血液肿瘤与实体瘤治疗中的进展、挑战与未来方向

Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments.

来自大肠杆菌的全长重组抗体：生产、表征、效应功能（Fc）工程化与临床评价

Full-length recombinant antibodies from Escherichia coli: production, characterization, effector function (Fc) engineering, and clinical evaluation.